Open Access

Upregulation of eukaryotic translation initiation factor 4E associates with a poor prognosis in gallbladder cancer and promotes cell proliferation in vitro and in vivo

  • Authors:
    • Debao Fang
    • Jing Peng
    • Guobing Wang
    • Dachen Zhou
    • Xiaoping Geng
  • View Affiliations

  • Published online on: August 19, 2019     https://doi.org/10.3892/ijmm.2019.4317
  • Pages: 1325-1332
  • Copyright: © Fang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Eukaryotic translation initiation factor 4 (eIF4E) has been demonstrated to promote tumorigenesis in different types of cancer; however, whether eIF4E is involved in the development of GBC is unclear. The present study aimed to explore the biological function of eIF4E in gallbladder cancer (GBC) and identified that the expression level of eIF4E was significantly increased in GBC tissues compared with that in normal gallbladder tissues. The overall survival (OS) was also shorter in the group of patients with GBC with increased eIF4E expression. Increased eIF4E was correlated with advanced stage and higher histologic grade. Knockdown of eIF4E significantly inhibited cell proliferation, colony formation and cell cycle‑associated protein expression levels in 2 GBC cell lines. The weight of the tumors in the eIF4E knockdown group was remarkably decreased compared with the control group. It also was revealed that knockdown of eIF4E is associated with upregulating cyclin‑dependent kinase inhibitor 1B and downregulating the expression levels of cyclin E1 and cyclin D1 in vitro and in vivo. These data demonstrated that eIF4E is a novel prognostic marker in GBC and may serve a critical role in the regulation of cell proliferation.

References

1 

Randi G, Franceschi S and La Vecchia C: Gallbladder cancer worldwide: Geographical distribution and risk factors. Int J Cancer. 118:1591–1602. 2006. View Article : Google Scholar : PubMed/NCBI

2 

Pitt SC, Jin LX, Hall BL, Strasberg SM and Pitt HA: Incidental gallbladder cancer at cholecystectomy: When should the surgeon be suspicious? Ann Surg. 260:128–133. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Elmasry M, Lindop D, Dunne DF, Malik H, Poston GJ and Fenwick SW: The risk of malignancy in ultrasound detected gallbladder polyps: A systematic review. Int J Surg. 33(Pt A): 28–35. 2016. View Article : Google Scholar : PubMed/NCBI

4 

Dasari BVM, Ionescu MI, Pawlik TM, Hodson J, Sutcliffe RP, Roberts KJ, Muiesan P, Isaac J, Marudanayagam R and Mirza DF: Outcomes of surgical resection of gallbladder cancer in patients presenting with jaundice: A systematic review and meta-analysis. J Surg Oncol. 118:477–485. 2018. View Article : Google Scholar : PubMed/NCBI

5 

Aitken CE and Lorsch JR: A mechanistic overview of translation initiation in eukaryotes. Nat Struct Mol Biol. 19:568–576. 2012. View Article : Google Scholar : PubMed/NCBI

6 

Pelletier J, Graff J, Ruggero D and Sonenberg N: Targeting the eIF4F translation initiation complex: A critical nexus for cancer development. Cancer Res. 75:250–263. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Ramaswamy S, Ross KN, Lander ES and Golub TR: A molecular signature of metastasis in primary solid tumors. Nat Genet. 33:49–54. 2003. View Article : Google Scholar

8 

Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th ed. Springer; New York, NY: 2010

9 

Lu Li M, Zhang J, Li F, Zhang H, Wu B, Tan X, Zhang Z, Gao L, Mu GJ, et al: Yes-associated protein 1 (YAP1) promotes human gallbladder tumor growth via activation of the AXL/MAPK pathway. Cancer Lett. 355:201–209. 2014. View Article : Google Scholar : PubMed/NCBI

10 

Yin X, Kim RH, Sun G, Miller JK and Li BD: Overexpression of eukaryotic initiation factor 4E is correlated with increased risk for systemic dissemination in node-positive breast cancer patients. J Am Coll Surg. 218:663–671. 2014. View Article : Google Scholar : PubMed/NCBI

11 

Khosravi S, Tam KJ, Ardekani GS, Martinka M, McElwee KJ and Ong CJ: eIF4E is an adverse prognostic marker of melanoma patient survival by increasing melanoma cell invasion. J Invest Dermatol. 135:1358–1367. 2015. View Article : Google Scholar : PubMed/NCBI

12 

Kwegyir-Afful AK, Bruno RD, Purushottamachar P, Murigi FN and Njar VC: Galeterone and VNPT55 disrupt Mnk-eIF4E to inhibit prostate cancer cell migration and invasion. FEBS J. 283:3898–3918. 2016. View Article : Google Scholar : PubMed/NCBI

13 

Liu F, Wang X, Li J, Gu K, Lv L, Zhang S, Che D, Cao J, Jin S and Yu Y: miR-34c-3p functions as a tumour suppressor by inhibiting eIF4E expression in non-small cell lung cancer. Cell Prolif. 48:582–592. 2015. View Article : Google Scholar : PubMed/NCBI

14 

Wiegering A, Uthe FW, Jamieson T, Ruoss Y, Hüttenrauch M, Küspert M, Pfann C, Nixon C, Herold S, Walz S, et al: Targeting translation initiation bypasses signaling crosstalk mechanisms that maintain high MYC levels in colorectal cancer. Cancer Discov. 5:768–781. 2015. View Article : Google Scholar : PubMed/NCBI

15 

Sonenberg N and Hinnebusch AG: Regulation of translation initiation in eukaryotes: Mechanisms and biological targets. Cell. 136:731–745. 2009. View Article : Google Scholar : PubMed/NCBI

16 

Siddiqui N and Sonenberg N: Signalling to eIF4E in cancer. Biochem Soc Trans. 43:763–772. 2015. View Article : Google Scholar : PubMed/NCBI

17 

Wan J, Shi F, Xu Z and Zhao M: Knockdown of eIF4E suppresses cell proliferation, invasion and enhances cisplatin cytotoxicity in human ovarian cancer cells. Int J Oncol. 47:2217–2225. 2015. View Article : Google Scholar : PubMed/NCBI

18 

Chen B, Zhang B, Xia L, Zhang J, Chen Y, Hu Q and Zhu C: Knockdown of eukaryotic translation initiation factor 4E suppresses cell growth and invasion, and induces apoptosis and cell cycle arrest in a human lung adenocarcinoma cell line. Mol Med Rep. 13:33842016. View Article : Google Scholar : PubMed/NCBI

19 

Truitt ML, Conn CS, Shi Z, Pang X, Tokuyasu T, Coady AM, Seo Y, Barna M and Ruggero D: Differential requirements for eIF4E dose in normal development and cancer. Cell. 162:59–71. 2015. View Article : Google Scholar : PubMed/NCBI

20 

Robichaud N, del Rincon SV, Huor B, Alain T, Petruccelli LA, Hearnden J, Goncalves C, Grotegut S, Spruck CH, Furic L, et al: Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3. Oncogene. 34:2032–2042. 2015. View Article : Google Scholar

21 

D'Abronzo LS, Bose S, Crapuchettes ME, Beggs RE, Vinall RL, Tepper CG, Siddiqui S, Mudryj M, Melgoza FU, Durbin-Johnson BP, et al: The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: Implications for the use of mTOR inhibitors in advanced prostate cancer. Oncogene. 36:6359–6373. 2017. View Article : Google Scholar : PubMed/NCBI

22 

Duffy AG, Makarova-Rusher OV, Ulahannan SV, Rahma OE, Fioravanti S, Walker M, Abdullah S, Raffeld M, Anderson V, Abi-Jaoudeh N, et al: Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancer. Int J Cancer. 139:1648–1657. 2016. View Article : Google Scholar : PubMed/NCBI

23 

Robichaud N, Hsu BE, Istomine R, Alvarez F, Blagih J, Ma EH, Morales SV, Dai DL, Li G, Souleimanova M, et al: Translational control in the tumor microenvironment promotes lung metastasis: Phosphorylation of eIF4E in neutrophils. Proc Natl Acad Sci USA. 115:E2202–E2209. 2018. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

October 2019
Volume 44 Issue 4

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Fang, D., Peng, J., Wang, G., Zhou, D., & Geng, X. (2019). Upregulation of eukaryotic translation initiation factor 4E associates with a poor prognosis in gallbladder cancer and promotes cell proliferation in vitro and in vivo. International Journal of Molecular Medicine, 44, 1325-1332. https://doi.org/10.3892/ijmm.2019.4317
MLA
Fang, D., Peng, J., Wang, G., Zhou, D., Geng, X."Upregulation of eukaryotic translation initiation factor 4E associates with a poor prognosis in gallbladder cancer and promotes cell proliferation in vitro and in vivo". International Journal of Molecular Medicine 44.4 (2019): 1325-1332.
Chicago
Fang, D., Peng, J., Wang, G., Zhou, D., Geng, X."Upregulation of eukaryotic translation initiation factor 4E associates with a poor prognosis in gallbladder cancer and promotes cell proliferation in vitro and in vivo". International Journal of Molecular Medicine 44, no. 4 (2019): 1325-1332. https://doi.org/10.3892/ijmm.2019.4317